Английская Википедия:Crinecerfont
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Orphan Шаблон:Infobox drug
Crinecerfont is a corticotropin-releasing factor type 1 receptor (CRF1R) antagonist developed to treat classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD). It is hoped to reduce the need for long-term, high dose glucocorticoid therapy and its associated adverse effects in people with CAH.[1][2][3][4]
References